Anjail Z Sharrief1, Brisa N Sánchez2, Lynda D Lisabeth3, Lesli E Skolarus4, Darin B Zahuranec4, Jonggyu Baek5, Nelda Garcia4, Erin Case5, Lewis B Morgenstern6. 1. University of Texas Medical School at Houston, Ann Arbor, Michigan. 2. Department of Biostatistics, University of Michigan School of Public Health, Ann Arbor, Michigan. 3. Department of Epidemiology, University of Michigan School of Public Health, Ann Arbor, Michigan; Stroke Program, University of Michigan Health System, Ann Arbor, Michigan. 4. Stroke Program, University of Michigan Health System, Ann Arbor, Michigan. 5. Department of Epidemiology, University of Michigan School of Public Health, Ann Arbor, Michigan. 6. Department of Epidemiology, University of Michigan School of Public Health, Ann Arbor, Michigan; Stroke Program, University of Michigan Health System, Ann Arbor, Michigan. Electronic address: lmorgens@umich.edu.
Abstract
BACKGROUND: Psychological and social factors have been linked to stroke mortality; however, their impact on stroke disability is unclear. The purpose of this study was to evaluate the impact of pre-stroke fatalism, depressive symptoms, and social support on 90-day neurologic, functional, and cognitive outcomes. METHODS: Ischemic strokes (2008-2011) were identified from the Brain Attack Surveillance in Corpus Christi Project. Validated scales were used to assess fatalism, depressive symptoms, and social support during baseline interviews. The National Institutes of Health Stroke Scale, activities of daily living/instrumental activities of daily living (ADL/IADL) scale, and Modified Mini-Mental State Exam (3MSE) were used to assess 90-day outcomes. The associations between the pre-stroke variables and 90-day outcomes were estimated from regression models adjusting for demographics, risk factors, tissue-type plasminogen activator treatment, and comorbidities. RESULTS: Among 364 stroke survivors, higher pre-stroke fatalism was associated with worse functional (.17 point higher ADL/IADL per interquartile range [IQR] higher fatalism; 95% confidence interval [CI]: .05, .30) and cognitive (2.81 point lower 3MSE per IQR higher fatalism; 95% CI: .95, 4.67) outcomes. Higher pre-stroke depressive symptoms were associated with worse functional (.16 point higher ADL/IADL per IQR higher Patient Health Questionnaire-9; 95% CI: .04, .28) and cognitive (2.28 point lower 3MSE per IQR higher Patient Health Questionnaire-9; 95% CI: .46, 4.10) outcomes. Participants in the middle tertile of social support had better cognitive outcomes (3.75 points higher 3MSE; 95% CI: .93, 6.56) compared with the highest tertile. CONCLUSIONS: The associations between pre-stroke fatalism, depressive symptoms, and social support and 90-day outcomes suggest that psychosocial factors play an important role in stroke recovery.
BACKGROUND: Psychological and social factors have been linked to stroke mortality; however, their impact on stroke disability is unclear. The purpose of this study was to evaluate the impact of pre-stroke fatalism, depressive symptoms, and social support on 90-day neurologic, functional, and cognitive outcomes. METHODS:Ischemic strokes (2008-2011) were identified from the Brain Attack Surveillance in Corpus Christi Project. Validated scales were used to assess fatalism, depressive symptoms, and social support during baseline interviews. The National Institutes of Health Stroke Scale, activities of daily living/instrumental activities of daily living (ADL/IADL) scale, and Modified Mini-Mental State Exam (3MSE) were used to assess 90-day outcomes. The associations between the pre-stroke variables and 90-day outcomes were estimated from regression models adjusting for demographics, risk factors, tissue-type plasminogen activator treatment, and comorbidities. RESULTS: Among 364 stroke survivors, higher pre-stroke fatalism was associated with worse functional (.17 point higher ADL/IADL per interquartile range [IQR] higher fatalism; 95% confidence interval [CI]: .05, .30) and cognitive (2.81 point lower 3MSE per IQR higher fatalism; 95% CI: .95, 4.67) outcomes. Higher pre-stroke depressive symptoms were associated with worse functional (.16 point higher ADL/IADL per IQR higher Patient Health Questionnaire-9; 95% CI: .04, .28) and cognitive (2.28 point lower 3MSE per IQR higher Patient Health Questionnaire-9; 95% CI: .46, 4.10) outcomes. Participants in the middle tertile of social support had better cognitive outcomes (3.75 points higher 3MSE; 95% CI: .93, 6.56) compared with the highest tertile. CONCLUSIONS: The associations between pre-stroke fatalism, depressive symptoms, and social support and 90-day outcomes suggest that psychosocial factors play an important role in stroke recovery.
Authors: Melinda A Smith; Jan M H Risser; Lemuel A Moyé; Nelda Garcia; Olubumi Akiwumi; Ken Uchino; Lewis B Morgenstern Journal: Ethn Dis Date: 2004 Impact factor: 1.847
Authors: Rebekah J Walker; Brittany L Smalls; Melba A Hernandez-Tejada; Jennifer A Campbell; Kimberly S Davis; Leonard E Egede Journal: Gen Hosp Psychiatry Date: 2012-08-13 Impact factor: 3.238
Authors: Ari L Harris; Jessica Elder; Nicholas D Schiff; Jonathan D Victor; Andrew M Goldfine Journal: Transl Stroke Res Date: 2013-10-19 Impact factor: 6.829
Authors: Paisith Piriyawat; Miriam Smajsová; Melinda A Smith; Sanjay Pallegar; Areej Al-Wabil; Nelda M Garcia; Jan M Risser; Lemuel A Moyé; Lewis B Morgenstern Journal: Am J Epidemiol Date: 2002-12-01 Impact factor: 4.897
Authors: Lauren E Fournier; Jennifer E Sanner Beauchamp; Xu Zhang; Esther Bonojo; Mary Love; Gabretta Cooksey; Evelyn Hinojosa; Munachi N Okpala; Sean I Savitz; Anjail Z Sharrief Journal: J Stroke Cerebrovasc Dis Date: 2020-01-13 Impact factor: 2.136
Authors: Xiaqing Jiang; Lu Wang; Lewis B Morgenstern; Christine T Cigolle; Edward S Claflin; Lynda D Lisabeth Journal: Neurology Date: 2020-10-06 Impact factor: 9.910
Authors: Jan Claassen; Yama Akbari; Sheila Alexander; Mary Kay Bader; Kathleen Bell; Thomas P Bleck; Melanie Boly; Jeremy Brown; Sherry H-Y Chou; Michael N Diringer; Brian L Edlow; Brandon Foreman; Joseph T Giacino; Olivia Gosseries; Theresa Green; David M Greer; Daniel F Hanley; Jed A Hartings; Raimund Helbok; J Claude Hemphill; H E Hinson; Karen Hirsch; Theresa Human; Michael L James; Nerissa Ko; Daniel Kondziella; Sarah Livesay; Lori K Madden; Shraddha Mainali; Stephan A Mayer; Victoria McCredie; Molly M McNett; Geert Meyfroidt; Martin M Monti; Susanne Muehlschlegel; Santosh Murthy; Paul Nyquist; DaiWai M Olson; J Javier Provencio; Eric Rosenthal; Gisele Sampaio Silva; Simone Sarasso; Nicholas D Schiff; Tarek Sharshar; Lori Shutter; Robert D Stevens; Paul Vespa; Walter Videtta; Amy Wagner; Wendy Ziai; John Whyte; Elizabeth Zink; Jose I Suarez Journal: Neurocrit Care Date: 2021-07-08 Impact factor: 3.210